Consumer staples exchange-traded funds sit at the intersection of defensive positioning and inflation-driven pricing power, two themes that continue to draw investor attention. The First Trust Consumer Staples AlphaDEX Fund (FXG) and the iShares Global Consumer Staples ETF (KXI) both target companies selling essential everyday goods, yet they follow fundamentally different paths. This matters because the funds are not interchangeable: FXG applies a factor-based, equal-weight tilt within U.S. staples, while KXI tracks a broad global, cap-weighted index. From what I see, grasping these structural differences is essential before making any allocation.
FXG seeks to track the StrataQuant Consumer Staples AlphaDEX Index, which applies the AlphaDEX selection methodology to U.S. consumer staples names from the Russell 1000 Index. Instead of market-cap weighting, the index uses a modified equal-dollar scheme aimed at capturing potential outperformance versus traditional benchmarks. The fund holds roughly 41 securities, a notably concentrated lineup for a staples product. Its top holdings have included PPC, MCK, INGR, COR, BG, SFD, GIS, and FRPT. This mix shows a clear tilt toward food producers, meat and protein companies, agricultural processors, and packaged-food distributors, along with a meaningful mid-cap allocation. FXG carries a 0.63% expense ratio and launched in May 2007. I also checked this using Tickeron’s AI Screener to see how the fund’s holdings compare to others in the industry.
KXI seeks to track the S&P Global 1200 Consumer Staples (Sector) Capped Index, a market-capitalization-weighted benchmark covering consumer staples companies across developed global markets. It is a straightforward passive product offering broad access to essential-goods producers, retailers, and household-product manufacturers worldwide. With roughly 95 to 100 holdings, KXI is anchored by mega-cap names including WMT, COST, PG, KO, PM, PEP, and MO, plus non-U.S. holdings such as Nestlé and Unilever. More than 90% of the portfolio is large-cap, and while the United States is the largest country weight, the fund adds exposure to the United Kingdom, Japan, Switzerland, France, and Canada. KXI’s net expense ratio stands at approximately 0.38%.
The consumer staples sector faces a mix of pressures. Cost-of-living challenges have encouraged value-seeking behavior, supporting discount retailers and private-label makers while squeezing margins for some branded producers. At the same time, weight-loss medications have prompted questions about long-term demand for packaged foods and beverages, leading many companies to adjust portfolios toward “better-for-you” options. Agricultural and food input costs remain variable, with trade policy and tariff shifts affecting protein and grain producers more directly in FXG’s food-heavy holdings. Tobacco regulation continues to influence names such as Philip Morris and Altria inside KXI. Overall, the sector’s defensive cash flows and pricing power have kept it relevant during uncertain periods, though stronger equity risk appetite can shift capital toward cyclicals.
Over recent cycles, KXI’s mega-cap, global makeup has delivered relatively steadier results, reflecting the durable earnings of large multinationals with diversified revenue streams. FXG’s smaller, concentrated portfolio has shown greater sensitivity to food commodity prices and single-stock events, leading to higher volatility. Its three-year beta has typically sat in the 0.5 to 0.6 range, still defensive, yet the mid-cap tilt and narrower holdings can amplify dispersion. Recent rotation within staples has favored diversified holdings like KXI that smooth swings across protein producers, grain processors, and discount retailers. FXG’s factor-based equal weighting can add upside when mid-cap food and distribution names lead, but it also brings higher cost, greater volatility, and more idiosyncratic risk. One thing that stands out is KXI’s lower expense ratio and broader footprint, which have supported more consistent risk-adjusted outcomes.
When comparing funds like these, I often rely on Tickeron’s AI Screener to quickly filter holdings, volatility metrics, and relative performance across the sector. It helps surface patterns and trends that might otherwise require manual review, keeping the analysis efficient without replacing deeper due diligence.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Indicator exited the oversold zone, 20 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on FXG as a result. In 80 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 41 of 47 cases over the following month. The odds of a continued upward trend are 87%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 258 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 179 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples